Validation of the new 2021 EASL algorithm for the noninvasive diagnosis of advanced fibrosis in NAFLD-Reference-Cited by-同舟云学术

Validation of the new 2021 EASL algorithm for the noninvasive diagnosis of advanced fibrosis in NAFLD

Published:2023-02-17 Issue:3 Volume:77 Page:920-930
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:

Author:

Canivet Clémence M.,Costentin Charlotte,Irvine Katharina M.,Delamarre Adèle,Lannes Adrien,Sturm Nathalie,Oberti Frederic,Patel Preya J.,Decaens Thomas,Irles‐Depé Marie,Fouchard Isabelle,Hermabessière Paul,Roux Marine,Barthelon Justine,Calès Paul,Powell Elizabeth E.,de Ledinghen Victor,Boursier Jérôme

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep.32665

Reference40 articles.

1. Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy‐proven NAFLD;J Hepatol,2017

2. Mortality in biopsy‐confirmed nonalcoholic fatty liver disease: results from a nationwide cohort;Gut,2021

3. Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: systematic review and meta‐analysis;Hepatology,2017

4. Prospective study of outcomes in adults with nonalcoholic fatty liver disease;N Engl J Med,2021

5. New sequential combinations of non‐invasive fibrosis tests provide an accurate diagnosis of advanced fibrosis in NAFLD;J Hepatol,2019

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Confirmatory biomarker diagnostic studies are not needed when transitioning from NAFLD to MASLD;Journal of Hepatology;2024-02

2. Algorithms for Early Detection of Silent Liver Fibrosis in the Primary Care Setting;Seminars in Liver Disease;2024-01-23

3. Prolonged release pirfenidone pharmacokinetics is modified in cirrhosis GENESIS study;Biomedicine & Pharmacotherapy;2023-12

4. Serum biomarkers for liver fibrosis assessment;Advances in Laboratory Medicine / Avances en Medicina de Laboratorio;2023-11-14

5. Diagnostic Accuracy of FibroScan-AST (FAST) Score for Identifying Severe Nonalcoholic Steatohepatitis in a Greek Cohort;Journal of Clinical and Experimental Hepatology;2023-11